Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec 5:10:240.
doi: 10.1186/1479-5876-10-240.

Opportunities and challenges of disease biomarkers: a new section in the Journal of Translational Medicine

Xiangdong Wang  1 , Peter A Ward
Affiliations

Opportunities and challenges of disease biomarkers: a new section in the Journal of Translational Medicine

Xiangdong Wang et al. J Transl Med. .

Retraction in

Abstract

Disease biomarkers are defined to diagnose various phases of diseases, monitor severities of diseases and responses to therapies, or predict prognosis of patients. Disease-specific biomarkers should benefit drug discovery and development, integrate multidisciplinary sciences, be validated by molecular imaging. The opportunities and challenges in biomarker development are emphasized and considered. The Journal of Translational Medicine opens a new Section of Disease Biomarkers to bridge identification and validation of gene or protein-based biomarkers, network biomarkers, dynamic network biomarkers in human diseases, patient phenotypes, and clinical applications. Disease biomarkers are also important for determining drug effects, target specificities and binding, dynamic metabolism and pharmacological kinetics, or toxicity profiles.

PubMed Disclaimer

References

    1. Kelloff GJ, Sigman CC. Cancer biomarkers: selecting the right drug for the right patient. Nat Rev Drug Discov. 2012;11:201–204. doi: 10.1038/nrd3651. - DOI - PubMed
    1. Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov. 2010;9(7):560–574. doi: 10.1038/nrd3115. - DOI - PubMed
    1. Wang XD, Liotta L. Clinical bioinformatics: a new emerging science. J Clin Bioinforma. 2011;1:1. doi: 10.1186/2043-9113-1-1. - DOI - PMC - PubMed
    1. Marko-Varga G, Végvári Á, Rezeli M, Prikk K, Ross P, Dahlbäck M, Edula G, Sepper R, Fehniger TF. Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine. Clin Transl Med. 2012;1:8. doi: 10.1186/2001-1326-1-8. - DOI - PMC - PubMed
    1. Chen H, Wang Y, Bai C, Wang XD. Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation. J Proteomics. 2012;75(10):2835–2843. doi: 10.1016/j.jprot.2012.01.027. - DOI - PubMed

Publication types

LinkOut - more resources